Bosh sahifaCAMX • STO
add
Camurus AB
Yopilish kursi
597,50 kr
Kunlik diapazon
595,00 kr - 607,00 kr
Yillik diapazon
483,80 kr - 754,50 kr
Bozor kapitalizatsiyasi
35,77 mlrd SEK
Oʻrtacha hajm
129,05 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 567,07 mln | 18,24% |
Joriy xarajat | 297,52 mln | -2,21% |
Sof foyda | 192,64 mln | 48,93% |
Sof foyda marjasi | 33,97 | 25,95% |
Har bir ulushga tushum | 3,19 | 47,69% |
EBITDA | 236,64 mln | 62,61% |
Amaldagi soliq stavkasi | 21,46% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,51 mlrd | 27,75% |
Jami aktivlari | 4,63 mlrd | 29,73% |
Jami passivlari | 510,02 mln | 12,29% |
Umumiy kapital | 4,12 mlrd | — |
Tarqatilgan aksiyalar | 59,61 mln | — |
Narxi/balansdagi bahosi | 8,65 | — |
Aktivlardan daromad | 12,72% | — |
Kapitaldan daromad | 14,04% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 192,64 mln | 48,93% |
Operatsiyalardan naqd pul | 160,46 mln | 7,21% |
Sarmoyadan naqd pul | -31,18 mln | -425,92% |
Moliyadan naqd pul | 39,36 mln | -7,37% |
Naqd pulning sof oʻzgarishi | 167,29 mln | -9,15% |
Boʻsh pul | 17,16 mln | -72,69% |
Haqida
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Tashkil etilgan
1991
Sayt
Xodimlar soni
280
